GW842166X

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GW842166X, covering 2015-02-16 to 2017-08-07. Get the full timeline:

Most recent: Clinical Trial Update: An Imaging Study to Investigate the Distribution of GW842166X in the Brain. [Phase 1]